IP Library Granted Patent US 11,697,836
Granted Patent B2
US 11,697,836 · App. 17/214,251 · Granted Jul 11, 2023

Normalization of NGS library concentration

Inventors: Vladimir Makarov (Ann Arbor, MI); Sergey Chupreta (Gregory, MI)
Assignee: Integrated DNA Technologies, Inc.
C12Q1/6806C12N15/00C12Q1/686C12Q1/6876C40B40/08
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,697,836
App. No.
17/214,251
Granted
Jul 11, 2023
Kind
B2
Abstract

A bottleneck in the Next Generation Sequencing (NGS) workflow is the quantification of libraries for accurate pooling and loading of the sequencing instrument flow cell or chip. Disclosed herein are methods that improve performance and reduce time compared to existing methods.

Claims (19)

1. A kit comprising:

a first primer comprising a first portion, a second portion and a third portion, wherein the first portion is located at a 3′ end of the first primer, wherein the second portion comprises 3 or more consecutive ribonucleotide bases and is located 5′ to the first portion, and wherein the third portion is located 5′ adjacent to the second portion and comprises two or more deoxynucleotides;

a second primer;

a ligase;

a probe, wherein the probe comprises a modification to provide resistance to digestion by an enzyme with 3′-5′ exonuclease activity, and wherein at least a portion of the probe is complementary to at least a portion of the third portion of the first primer and to the three or more consecutive ribonucleotide bases; and

an exonuclease.

2. The kit of claim 1 , wherein the ligase is T4 DNA ligase.

3. The kit of claim 1 , wherein the exonuclease is Exonuclease III.

4. The kit of claim 1 , wherein the second primer further comprises a fourth portion, a fifth portion comprising 3 or more consecutive ribonucleotide bases located 5′ adjacent to the fourth portion and a sixth portion located 5′ adjacent to the fifth portion and comprising two or more deoxynucleotides.

5. The kit of claim 1 , further comprising a thermostable polymerase with 3′-5′ exonuclease proofreading activity.

6. The kit of claim 1 , wherein the third portion of the first primer comprises a low complexity sequence selected from the group consisting of poly(A), poly(T), poly(G), poly(C), poly(AG), poly(AC), poly(GT), poly(CT), poly(AT), poly(GC), a trinucleotide, a tetranucleotide, and a pentanucleotide.

7. The kit of claim 1 , wherein the probe comprises single-stranded DNA, and wherein the probe comprises a 5′ phosphate.

8. A kit comprising:

a first primer comprising a first portion, a second portion, and a third portion, wherein the first portion is located at a 3′ end of the first primer, wherein the second portion comprises 3 or more consecutive ribonucleotide bases and is located 5′ to the first portion, and wherein the third portion is located 5′ adjacent to the second portion and comprises a low complexity sequence selected from the group consisting of poly(A), poly(T), poly(G), poly(C), poly(AG), poly(AC), poly(GT), poly(CT), poly(AT), poly(GC), a trinucleotide, a tetranucleotide, and a pentanucleotide;

a second primer;

a ligase;

a probe, wherein the probe comprises a modification to provide resistance to digestion by an enzyme with exonuclease activity; and

an exonuclease.

9. The kit of claim 8 , wherein the probe comprises a sequence complimentary to the low complexity sequence.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 29, 2022
From: MAKAROV, VLADIMIR; CHUPRETA, SERGEY
To: SWIFT BIOSCIENCES, INC.
Reel/Frame 059770/0292 →
MERGER Recorded Apr 15, 2022
From: SWIFT BIOSCIENCES, INC.
To: INTEGRATED DNA TECHNOLOGIES, INC.
Reel/Frame 059606/0848 →
Continuity (4)
Continuation 16294561 · Mar 6, 2019
Continuation PCTUS2017050354 · Sep 6, 2017
Provisional Application 62384118 · Sep 6, 2016
Related Publication 20210277447A1 · Sep 9, 2021
Cited By (1)
US 12,371,731